Jessica Bennett, APRN
Nurse Practitioner · Corbin, KYNPI 1346870458
Payments from drug & device makers
Across 114 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$230
- AbbVie$213
- Vanda Pharmaceuticals Inc.$210
- Lilly USA, LLC$152
- Novartis$149
- GSK$147
- plus $845 from 19 others
What the payments were for
- Food & beverage$1,947100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $230 |
| AbbVie | 13 | $213 |
| Vanda Pharmaceuticals Inc. | 10 | $210 |
| Lilly USA, LLC | 10 | $152 |
| Novartis | 8 | $149 |
| GSK | 8 | $147 |
| Bayer | 7 | $130 |
| Amgen | 8 | $122 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| AstraZeneca(2 entities) | 5 | $80 |
| Ironshore Pharmaceuticals Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Exact Sciences | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Ardelyx, Inc. | 1 | $21 |
| Inogen, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
How this compares
$1,947 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 37 | $48,411 |
| OzempicSemaglutide | 32 | $36,353 |
| JardianceEmpagliflozin | 20 | $21,320 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $6,931 |
| LinzessLinaclotide | 12 | $6,346 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $6,292 |
| Aripiprazole | 12 | $2,323 |
| Atorvastatin Calcium | 99 | $704 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $648 |
| Omeprazole | 70 | $604 |
| Levocetirizine Dihydrochloride | 22 | $591 |
| Pantoprazole Sodium | 69 | $495 |
| Levothyroxine Sodium | 88 | $456 |
| Quetiapine Fumarate | 39 | $441 |
| Levetiracetam | 20 | $428 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $152 | $48,41137 claims |
| Novo NordiskOzempic | $230 | $36,35332 claims |
| Boehringer IngelheimJardiance | $13 | $21,32020 claims |
| AbbVieLinzess | $213 | $6,34612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Corbin
- Whitney BartonCorbin$14K
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.